Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $99.5400 (0.6%) ($98.3500 - $100.3200) on Mon. Sep. 30, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.92% (three month average) | RSI | 69 | Latest Price | $99.5400(0.6%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1.1% a day on average for past five trading days. | Weekly Trend | LGND advances 1.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(60%) IWO(57%) XBI(55%) IWC(54%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.46% in a week (0% probabilities). VIXM(-33%) VXX(-20%) TLT(-15%) UUP(-4%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.46% (StdDev 2.92%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $99.49(0.05%) | 10 Day Moving Average | $100.89(-1.34%) | 20 Day Moving Average | $96.66(2.98%) | To recent high | -17.2% | To recent low | 15.4% | Market Cap | $1.6b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |